BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31095043)

  • 1. Radioiodine remnant ablation in papillary thyroid microcarcinoma: a meta-analysis.
    Yang T; Zheng SY; Jiao J; Zou Q; Zhang Y
    Nucl Med Commun; 2019 Jul; 40(7):711-719. PubMed ID: 31095043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effectiveness of Radioactive Iodine Remnant Ablation for Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-analysis.
    Hu G; Zhu W; Yang W; Wang H; Shen L; Zhang H
    World J Surg; 2016 Jan; 40(1):100-9. PubMed ID: 26578322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of Efficacy of Radioiodine Remnant Ablation for Papillary Thyroid Microcarcinoma: Verification Using Inverse Probability of Treatment Weighting.
    Kwon H; Jeon MJ; Kim WG; Park S; Kim M; Kim TY; Han M; Song DE; Sung TY; Yoon JH; Hong SJ; Ryu JS; Shong YK; Kim WB
    Ann Surg Oncol; 2017 Sep; 24(9):2596-2602. PubMed ID: 28600731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of recurrence rates in papillary thyroid microcarcinoma patients with and without histopathological risk factors after radioiodine ablation treatment.
    Soydal C; Araz M; Ozkan E; Arslantaş E; Kucuk ON; Aras G
    Nucl Med Commun; 2015 Feb; 36(2):109-13. PubMed ID: 25321158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of Life in Patients with Papillary Thyroid Microcarcinoma According to Treatment: Total Thyroidectomy with or without Radioactive Iodine Ablation.
    Ahn J; Jeon MJ; Song E; Kim TY; Kim WB; Shong YK; Kim WG
    Endocrinol Metab (Seoul); 2020 Mar; 35(1):115-121. PubMed ID: 32207271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioactive Iodine Ablation Can Reduce the Structural Recurrence Rate of Intermediate-Risk Papillary Thyroid Microcarcinoma: A Meta-Analysis.
    Zhao M; Shi X; Zhang J; Deng S; Zhou Y; Wen R; Lu Y; Zhang B
    Comput Math Methods Med; 2022; 2022():8028846. PubMed ID: 36110571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma.
    Kim HJ; Kim NK; Choi JH; Kim SW; Jin SM; Suh S; Bae JC; Min YK; Chung JH; Kim SW
    Clin Endocrinol (Oxf); 2013 Apr; 78(4):614-20. PubMed ID: 22957654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment for microcarcinoma of the thyroid--clinical experience.
    Küçük NO; Tari P; Tokmak E; Aras G
    Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioactive iodine remnant uptake after completion thyroidectomy: not such a complete cancer operation.
    Oltmann SC; Schneider DF; Leverson G; Sivashanmugam T; Chen H; Sippel RS
    Ann Surg Oncol; 2014 Apr; 21(4):1379-83. PubMed ID: 24378987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioactive iodine administered for thyroid remnant ablation following recombinant human thyroid stimulating hormone preparation also has an important adjuvant therapy function.
    Tuttle RM; Lopez N; Leboeuf R; Minkowitz SM; Grewal R; Brokhin M; Omry G; Larson S
    Thyroid; 2010 Mar; 20(3):257-63. PubMed ID: 20187781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of the factors affecting the efficacy of (131)I remnant ablation in patients after thyroidectomy for papillary thyroid microcarcinoma].
    Du F; Hu S; Wu C; Cheng Y; Wu LX; Liu JZ; Wu ZF; Li SJ
    Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):610-613. PubMed ID: 30139032
    [No Abstract]   [Full Text] [Related]  

  • 12. Radioiodine Remnant Ablation for Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis.
    James DL; Ryan ÉJ; Davey MG; Quinn AJ; Heath DP; Garry SJ; Boland MR; Young O; Lowery AJ; Kerin MJ
    JAMA Otolaryngol Head Neck Surg; 2021 Jun; 147(6):544-552. PubMed ID: 33792650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioactive Iodine Ablation Decrease Recurrences in Papillary Thyroid Microcarcinoma with Lateral Lymph Node Metastasis in Chinese Patients.
    Xue S; Wang P; Liu J; Chen G
    World J Surg; 2017 Dec; 41(12):3139-3146. PubMed ID: 28741199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of tumor size and focality with recurrence/persistence in papillary thyroid cancer patients treated with total thyroidectomy along with radioactive-iodine ablation and TSH suppression.
    Khan M; Syed AA; Khan AI; Hussain SR; Urooj N
    Updates Surg; 2018 Mar; 70(1):121-127. PubMed ID: 28550398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients.
    Roti E; Rossi R; Trasforini G; Bertelli F; Ambrosio MR; Busutti L; Pearce EN; Braverman LE; Degli Uberti EC
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2171-8. PubMed ID: 16478817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher administered activities of radioactive iodine are associated with less structural persistent response in older, but not younger, papillary thyroid cancer patients with lateral neck lymph node metastases.
    Sabra MM; Grewal RK; Ghossein RA; Tuttle RM
    Thyroid; 2014 Jul; 24(7):1088-95. PubMed ID: 24559250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of surgical completeness in endoscopic thyroidectomy compared with open thyroidectomy with regard to remnant ablation.
    Im HJ; Koo do H; Paeng JC; Lee KE; Chung YS; Lim I; Lee DS; Chung JK; Youn YK
    Clin Nucl Med; 2012 Feb; 37(2):148-51. PubMed ID: 22228337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-Dose Radioactive Iodine Ablation Is Sufficient in Patients With Small Papillary Thyroid Cancer Having Minor Extrathyroidal Extension and Central Lymph Node Metastasis (T3 N1a).
    Seo M; Kim YS; Lee JC; Han MW; Kim ES; Kim KB; Park SH
    Clin Nucl Med; 2017 Nov; 42(11):842-846. PubMed ID: 28832376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment efficacy between total thyroidectomy and lobectomy for patients with papillary thyroid microcarcinoma: A systemic review and meta-analysis.
    Zheng W; Li J; Lv P; Chen Z; Fan P
    Eur J Surg Oncol; 2018 Nov; 44(11):1679-1684. PubMed ID: 30158063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer--is there a need for radioactive iodine therapy?
    Ibrahimpasic T; Nixon IJ; Palmer FL; Whitcher MM; Tuttle RM; Shaha A; Patel SG; Shah JP; Ganly I
    Surgery; 2012 Dec; 152(6):1096-105. PubMed ID: 23158181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.